Correction to: Clinical prospective study of Gallium 68 (68Ga)-labeled fibroblast‑activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma
Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2230.
doi: 10.1007/s00259-023-06188-2.
1 Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
2 Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China.
3 Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
4 Department of Hepatobiliary and Pancreatic Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
5 Department of Hepatobiliary Surgery, Jingzhou Central Hospital, Jingzhou, Hubei, China.
6 Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. zhonglinzhang@whu.edu.cn.
7 Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China. zhonglinzhang@whu.edu.cn.
8 Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China. heyong@znhospital.cn.
9 Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. heyong@znhospital.cn.
10 Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. yuanyf1971@whu.edu.cn.
11 Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary &, Pancreatic Diseases of Hubei Province, Wuhan, Hubei, China. yuanyf1971@whu.edu.cn.
12 TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, Hubei, China. yuanyf1971@whu.edu.cn.